Journal article

Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer

NM Corcoran, CM Hovens, M Michael, MA Rosenthal, AJ Costello

British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2010